Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CanCog Technologies is a specialized contract research organization (CRO) that provides translational research services using canine models of aging and cognition. The company is best known for its proprietary CanCog Cognitive Test Battery, a validated platform for assessing learning, memory, and executive function in dogs. These models are highly valued in the pharmaceutical and nutraceutical industries for their ability to mimic human neurodegenerative conditions, such as Alzheimer's disease, more accurately than traditional rodent models. CanCog's services include efficacy testing for drug candidates, medical foods, and dietary supplements aimed at treating cognitive decline. Following its acquisition by InterVivo Solutions, the company continues to lead in the field of veterinary and human translational neuroscience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancog Technologies.